Molina Healthcare Inc (MOH) - Net Assets
Based on the latest financial reports, Molina Healthcare Inc (MOH) has net assets worth $4.07 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($15.56 Billion) and total liabilities ($11.49 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Molina Healthcare Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.07 Billion |
| % of Total Assets | 26.14% |
| Annual Growth Rate | 22.53% |
| 5-Year Change | 54.71% |
| 10-Year Change | 146.76% |
| Growth Volatility | 31.68 |
Molina Healthcare Inc - Net Assets Trend (1999–2025)
This chart illustrates how Molina Healthcare Inc's net assets have evolved over time, based on quarterly financial data. Also explore Molina Healthcare Inc assets under control for the complete picture of this company's asset base.
Annual Net Assets for Molina Healthcare Inc (1999–2025)
The table below shows the annual net assets of Molina Healthcare Inc from 1999 to 2025. For live valuation and market cap data, see Molina Healthcare Inc (MOH) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $4.07 Billion | -9.50% |
| 2024-12-31 | $4.50 Billion | +6.67% |
| 2023-12-31 | $4.21 Billion | +42.21% |
| 2022-12-31 | $2.96 Billion | +12.70% |
| 2021-12-31 | $2.63 Billion | +25.48% |
| 2020-12-31 | $2.10 Billion | +6.94% |
| 2019-12-31 | $1.96 Billion | +19.00% |
| 2018-12-31 | $1.65 Billion | +23.19% |
| 2017-12-31 | $1.34 Billion | -18.92% |
| 2016-12-31 | $1.65 Billion | +5.91% |
| 2015-12-31 | $1.56 Billion | +54.16% |
| 2014-12-31 | $1.01 Billion | +13.11% |
| 2013-12-31 | $892.94 Million | +14.14% |
| 2012-12-31 | $782.31 Million | +3.61% |
| 2011-12-31 | $755.07 Million | +5.01% |
| 2010-12-31 | $719.06 Million | +32.49% |
| 2009-12-31 | $542.74 Million | +6.28% |
| 2008-12-31 | $510.66 Million | +4.12% |
| 2007-12-31 | $490.48 Million | +16.73% |
| 2006-12-31 | $420.17 Million | +15.80% |
| 2005-12-31 | $362.85 Million | +9.75% |
| 2004-12-31 | $330.62 Million | +49.39% |
| 2003-12-31 | $221.32 Million | +132.32% |
| 2002-12-31 | $95.27 Million | +47.11% |
| 2001-12-31 | $64.76 Million | +87.13% |
| 2000-12-31 | $34.61 Million | +67.63% |
| 1999-12-31 | $20.64 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Molina Healthcare Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 360200000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $3.60 Billion | 88.52% |
| Common Stock | $51.00K | 0.00% |
| Other Comprehensive Income | $15.00 Million | 0.37% |
| Other Components | $451.95 Million | 11.11% |
| Total Equity | $4.07 Billion | 100.00% |
Molina Healthcare Inc Competitors by Market Cap
The table below lists competitors of Molina Healthcare Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Yongxing Special Stainless Steel Co Ltd
SHE:002756
|
$6.97 Billion |
|
Ormat Technologies Inc
NYSE:ORA
|
$6.98 Billion |
|
GEM Co Ltd
SHE:002340
|
$6.98 Billion |
|
Linde India Limited
NSE:LINDEINDIA
|
$6.99 Billion |
|
Abivax SA
PA:ABVX
|
$6.97 Billion |
|
New Gold Inc
TO:NGD
|
$6.96 Billion |
|
Cidara Therapeutics Inc
NASDAQ:CDTX
|
$6.96 Billion |
|
RATIONAL UN.ADR 1/ 1/20
F:RAA1
|
$6.96 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Molina Healthcare Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,496,000,000 to 4,069,000,000, a change of -427,000,000 (-9.5%).
- Net income of 472,000,000 contributed positively to equity growth.
- Share repurchases of 1,000,000,000 reduced equity.
- Other comprehensive income increased equity by 72,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $472.00 Million | +11.6% |
| Share Repurchases | $1.00 Billion | -24.58% |
| Other Comprehensive Income | $72.00 Million | +1.77% |
| Other Changes | $29.00 Million | +0.71% |
| Total Change | $- | -9.50% |
Book Value vs Market Value Analysis
This analysis compares Molina Healthcare Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.46x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 289.39x to 2.46x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-12-31 | $0.68 | $197.44 | x |
| 2000-12-31 | $1.13 | $197.44 | x |
| 2001-12-31 | $2.10 | $197.44 | x |
| 2002-12-31 | $3.08 | $197.44 | x |
| 2003-12-31 | $6.52 | $197.44 | x |
| 2004-12-31 | $8.06 | $197.44 | x |
| 2005-12-31 | $8.63 | $197.44 | x |
| 2006-12-31 | $9.95 | $197.44 | x |
| 2007-12-31 | $11.51 | $197.44 | x |
| 2008-12-31 | $12.26 | $197.44 | x |
| 2009-12-31 | $13.92 | $197.44 | x |
| 2010-12-31 | $17.27 | $197.44 | x |
| 2011-12-31 | $16.26 | $197.44 | x |
| 2012-12-31 | $16.65 | $197.44 | x |
| 2013-12-31 | $19.00 | $197.44 | x |
| 2014-12-31 | $21.04 | $197.44 | x |
| 2015-12-31 | $27.80 | $197.44 | x |
| 2016-12-31 | $29.45 | $197.44 | x |
| 2017-12-31 | $23.88 | $197.44 | x |
| 2018-12-31 | $24.58 | $197.44 | x |
| 2019-12-31 | $30.53 | $197.44 | x |
| 2020-12-31 | $34.99 | $197.44 | x |
| 2021-12-31 | $44.88 | $197.44 | x |
| 2022-12-31 | $50.67 | $197.44 | x |
| 2023-12-31 | $72.55 | $197.44 | x |
| 2024-12-31 | $77.92 | $197.44 | x |
| 2025-12-31 | $80.11 | $197.44 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Molina Healthcare Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.60%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.04%
- • Asset Turnover: 2.92x
- • Equity Multiplier: 3.83x
- Recent ROE (11.60%) is below the historical average (17.60%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 45.79% | 5.09% | 1.83x | 4.92x | $7.39 Million |
| 2000 | 43.24% | 4.54% | 3.23x | 2.95x | $11.50 Million |
| 2001 | 46.52% | 5.98% | 3.37x | 2.31x | $23.65 Million |
| 2002 | 32.02% | 4.74% | 3.14x | 2.15x | $20.98 Million |
| 2003 | 19.21% | 5.36% | 2.30x | 1.56x | $20.38 Million |
| 2004 | 16.87% | 4.75% | 2.20x | 1.61x | $22.71 Million |
| 2005 | 7.61% | 1.67% | 2.65x | 1.71x | $-8.69 Million |
| 2006 | 10.88% | 2.28% | 2.32x | 2.06x | $3.71 Million |
| 2007 | 11.89% | 2.34% | 2.13x | 2.39x | $9.28 Million |
| 2008 | 12.22% | 2.00% | 2.71x | 2.25x | $11.33 Million |
| 2009 | 5.69% | 0.84% | 2.95x | 2.29x | $-23.41 Million |
| 2010 | 7.64% | 1.35% | 2.71x | 2.10x | $-16.94 Million |
| 2011 | 2.76% | 0.44% | 2.89x | 2.19x | $-54.69 Million |
| 2012 | 1.25% | 0.16% | 3.12x | 2.47x | $-68.44 Million |
| 2013 | 5.93% | 0.80% | 2.19x | 3.36x | $-36.36 Million |
| 2014 | 6.16% | 0.64% | 2.18x | 4.39x | $-38.78 Million |
| 2015 | 9.18% | 1.02% | 2.14x | 4.22x | $-12.70 Million |
| 2016 | 0.49% | 0.05% | 2.38x | 4.52x | $-156.90 Million |
| 2017 | -38.29% | -2.58% | 2.35x | 6.34x | $-645.70 Million |
| 2018 | 42.93% | 3.74% | 2.64x | 4.34x | $542.30 Million |
| 2019 | 37.60% | 4.38% | 2.48x | 3.46x | $541.00 Million |
| 2020 | 32.11% | 3.46% | 2.04x | 4.55x | $463.40 Million |
| 2021 | 25.06% | 2.37% | 2.27x | 4.64x | $396.00 Million |
| 2022 | 26.72% | 2.48% | 2.60x | 4.15x | $495.60 Million |
| 2023 | 25.88% | 3.20% | 2.29x | 3.53x | $669.50 Million |
| 2024 | 26.22% | 2.90% | 2.60x | 3.48x | $729.40 Million |
| 2025 | 11.60% | 1.04% | 2.92x | 3.83x | $65.10 Million |
Industry Comparison
This section compares Molina Healthcare Inc's net assets metrics with peer companies in the Healthcare Plans industry.
Industry Context
- Industry: Healthcare Plans
- Average net assets among peers: $3,729,534,873
- Average return on equity (ROE) among peers: 1.44%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Molina Healthcare Inc (MOH) | $4.07 Billion | 45.79% | 2.83x | $6.97 Billion |
| Alignment Healthcare LLC (ALHC) | $30.61 Million | -74.89% | 10.06x | $3.71 Billion |
| Cigna Corp (CI) | $5.41 Billion | 17.46% | 16.57x | $74.29 Billion |
| Clover Health Investments Corp (CLOV) | $-54.83 Million | 0.00% | 0.00x | $1.00 Billion |
| Centene Corp (CNC) | $64.09 Million | 20.12% | 1.05x | $19.48 Billion |
| CVS Health Corp (CVS) | $1.72 Billion | 23.13% | 0.76x | $101.04 Billion |
| Elevance Health Inc (ELV) | $23.80 Billion | 11.16% | 1.53x | $63.54 Billion |
| Humana Inc (HUM) | $3.05 Billion | 15.96% | 2.32x | $22.79 Billion |
| Marpai Inc (MRAI) | $-873.14K | 0.00% | 0.00x | $6.05 Million |
| NeueHealth Inc (NEUE) | $-464.07 Million | 0.00% | 0.00x | $60.94 Million |
About Molina Healthcare Inc
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company was founded in 1980 and is headquartered in Long Beach, California.